March 12, 2020 / 6:07 AM / 16 days ago

BRIEF-Vifor Pharma FY EBITDA Of CHF 540.0 Million, Up 37.9%

March 12 (Reuters) - Vifor Pharma AG:

* VIFOR PHARMA GROUP REPORTS STRONG GROWTH IN 2019, EXCEEDING RAISED GUIDANCE

* FY NET SALES OF CHF 1,887.2 MILLION, UP 18.5%

* IN 2020 AT CONSTANT EXCHANGE RATES, VIFOR PHARMA NET SALES* ARE EXPECTED TO GROW IN RANGE OF 10%, REPORTED EBITDA IS EXPECTED TO GROW BY MORE THAN 25%. Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below